Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

Removing both ovaries treated the woman's excess male hormone symptoms.

An ovarian tumor caused a woman's male-like symptoms, which improved after surgery.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Significant facial gender transformation requires surgery, not nonsurgical methods.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

The document concludes that careful planning and execution of facial gender affirmation surgery after at least 12 months of hormonal therapy can improve the quality of life for transgender individuals.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Spironolactone may help enlarge a small breast linked to Becker's nevus.

Parental support and gender-affirming care are crucial for the mental health of transgender adolescents.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Surgery removed ovarian tumors, normalizing testosterone and improving symptoms.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

A rare, non-cancerous ovarian tumor was successfully treated with surgery, improving the patient's symptoms.